PeptideStack
5.2kquestions
20kanswers
220users

How do I reconcile 99.4% from VendorInvestigate with 98.4% from the supplier?

Asked 12 Jul 2024Modified 21 months agoViewed 58k times
29

Conditions: 99.4% · VendorInvestigate · 98.4%.

I have two candidate explanations and no way to distinguish them.

The same procedure has worked without incident several times previously, which argues against technique.

Is this recoverable, and how would I tell?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
shareeditfollowflag
TM
askedtwo_two_micron15k1712 Jul 2024
3Have you seen anything published on this, or is it inference from the mechanism? – triple_agonist_q 6 months ago
4Useful. I have added the accept threshold suggestion to my own notes. – Dr_Bram_Verhoeven 8 months ago
add a comment

5 Answers

Accepted answer first, then by votes
53

Accepted answer

To be exact about it, the short answer is that two competent laboratories on identical material will disagree, and the disagreement is almost always explainable by method differences.

Retention time is sequence-specific and method-specific, so comparing your result to a supplier value using a different method is meaningless without method documentation.

It helps to be literal here: column pore size affects mass transfer — a 100 Angstrom packing on a 5 kDa peptide restricts diffusion, broadening the peak and potentially hiding small impurities in the shoulders.

The ICH Q3A impurity thresholds and the relevant pharmacopoeial chapters all specify method validation requirements that almost no research-grade certificate claims to meet.

Compare purity within a single laboratory on the same method, never across laboratories.

edited 8 Aug 2024 by Dr_Yusuf_Adeyemi — reworded for clarity after a comment

shareimprove this answerflag
DA
answered · acceptedDr_Yusuf_Adeyemi95k2482 Aug 2024
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
47

Purity is a method-dependent figure, and that is not a limitation of the measurement, it is a property of what the measurement actually answers.

Sample solvent strength affects peak shape — if you inject in strong solvent on a gradient starting in weak solvent, the solvent peak can distort your main peak or create a false shoulder.

The part that matters: mass on column affects detector linearity and peak overlap — overloading broadens peaks and hides neighbours, while underloading improves resolution but loses sensitivity.

Proline conformer interconversion kinetics are well-characterised and the half-life is of the same order as the chromatographic peak width at room temperature.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

shareimprove this answerflag
BU
answeredbufferline4249k13822 Jul 2024
2Thank you — the worked example is what makes this usable. – rae_oyelowo 32 days ago
Related: the same reasoning applies to the counter-ion question. – tobias_maartens 9 months ago
add a comment
22

Read the chromatogram before you read the number, because the number without the trace is not a measurement, it is a claim.

Gradient slope controls resolution, and gentler slopes resolve co-eluting impurities into separate peaks — so the better method reports the worse purity number.

The underlying point is that buffer versus acid in the mobile phase changes the ionisation state of basic and acidic residues, shifting retention and selectivity — same vial, potentially different separation.

If you are ranking vendors, specify a method and have all samples tested at the same place.

shareimprove this answerflag
DK
answeredDr_Sara_Kuusela46k3828 Oct 2024
6I would gently push back on the second point — the evidence there is thinner than stated. – Dr_Malik_Osei 9 months ago
7Adding for future readers: the certificate should carry the lot number, not just a batch code. – fib4_reader 30 days ago
add a comment
17

Gradient slope is the most powerful parameter and almost nobody mentions it, which is why two reports on the same material disagree by a point.

Integration of the shoulder — whether you use perpendicular drop or tangent skim — determines what area gets assigned to the main peak versus the impurity table.

The Arrhenius relationship for peptide degradation is the basis of accelerated stability testing and also governs how quickly methods drift with temperature.

Worth noting that method standardisation is poor in the research-grade space compared to pharmaceutical work, so identical-looking methods can produce different results.

Compare purity within a single laboratory on the same method, never across laboratories.

shareimprove this answerflag
JW
answeredj_wierzbicki45k388 Nov 2024
3The distinction between purity and content cannot be repeated often enough here. – fib4_reader 3 months ago
add a comment
14

The single most important distinction is between what purity measures — the fraction of detected material that is your target — and what you actually want to know — how much of the material in the vial is your target.

Mobile phase additive choice affects ionisation and peak shape — TFA gives sharp peaks but suppresses mass spectrometry signal, formic acid gives worse peaks but preserves signal.

Published side-by-side method comparisons show that a two-point difference in purity on the same vial is easily explained by method choice alone.

The practical summary: ask for the chromatogram and the method, and ignore the headline number until you have both.

edited 7 Sept 2024 by retest_please — added a caveat about sampling

shareimprove this answerflag
RP
answeredretest_please13k284 Sept 2024
2I tested this on two lots and got the same answer, so at least it reproduces. – Dr_Sara_Kuusela 5 months ago
3The timing signature is the useful part. Everything else is confounded. – j_wierzbicki 6 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.